HLA-E and COVID-19: Hammer et al. reported that a SARS-CoV-2 peptide from the non-structural protein (Nsp) 13 can be presented by HLA-E, activating NKG2A+ NK cells in individuals with COVID-19, and restricting SARS-CoV-2 replication in infected lung epithelial cells in vitro [54].